ArticleCardiovascular research2024

Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy.

Jingrui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.